Episteme Prognostics

New York, United States

Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.

$4.1M raised

Apr 2023

Seed

Biotechnology Health Care Health Diagnostics Medical Precision Medicine

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Episteme Prognostics

How much funding has Episteme Prognostics raised?

Episteme Prognostics has raised $4.1M in total funding. The most recent round was Seed. The last funding was announced in April 2023.

Where is Episteme Prognostics headquartered?

Episteme Prognostics is headquartered in New York, United States.

What does Episteme Prognostics do?

Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.

What stage is Episteme Prognostics at?

Episteme Prognostics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 13, 2023.

MLA

"Episteme Prognostics — Funding & Investors." VCBacked, April 13, 2023, https://www.vcbacked.co/company/episteme-prognostics. Accessed July 2, 2026.

APA

VCBacked. (2023). Episteme Prognostics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/episteme-prognostics

Wikipedia (cite web)

{{cite web |title=Episteme Prognostics — Funding & Investors |url=https://www.vcbacked.co/company/episteme-prognostics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 13, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K